| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium
|
Gan, Liang-Shang L.
|
|
1997
|
23 |
1-3 |
p. 77-98
22 p.
|
artikel
|
| 2 |
Discrimination between drug candidates using models for evaluation of intestinal absorption
|
Stewart, Barbra H.
|
|
1997
|
23 |
1-3 |
p. 27-45
19 p.
|
artikel
|
| 3 |
Editorial Board
|
|
|
1997
|
23 |
1-3 |
p. ii-
1 p.
|
artikel
|
| 4 |
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
|
Lipinski, Christopher A.
|
|
1997
|
23 |
1-3 |
p. 3-25
23 p.
|
artikel
|
| 5 |
Immobilized Artificial Membranes — screens for drug membrane interactions
|
Yang, Cheng Y.
|
|
1997
|
23 |
1-3 |
p. 229-256
28 p.
|
artikel
|
| 6 |
Immobilized liposome chromatography of drugs for model analysis of drug-membrane interactions
|
Lundahl, Per
|
|
1997
|
23 |
1-3 |
p. 221-227
7 p.
|
artikel
|
| 7 |
In vitro models for selection of development candidates. Permeability studies to define mechanisms of absorption enhancement
|
LeCluyse, Edward L.
|
|
1997
|
23 |
1-3 |
p. 163-183
21 p.
|
artikel
|
| 8 |
In vitro models to predict blood-brain barrier permeability
|
Eddy, Evangeline Priya
|
|
1997
|
23 |
1-3 |
p. 185-198
14 p.
|
artikel
|
| 9 |
In vitro permeability of peptidomimetic drugs: The role of polarized efflux pathways as additional barriers to absorption
|
Burton, Philip S.
|
|
1997
|
23 |
1-3 |
p. 143-156
14 p.
|
artikel
|
| 10 |
In vitro permeability screening for identification of orally bioavailable endothelin receptor antagonists
|
Ellens, Harma
|
|
1997
|
23 |
1-3 |
p. 99-109
11 p.
|
artikel
|
| 11 |
Multiple-model evaluation of absorption of a tachykinin receptor antagonist
|
Chan, O.Helen
|
|
1997
|
23 |
1-3 |
p. 121-131
11 p.
|
artikel
|
| 12 |
Non-antibiotic anti-diarrhoeal drugs: factors affecting oral bioavailability of berberine and loperamide in intestinal tissue
|
Baird, Alan W.
|
|
1997
|
23 |
1-3 |
p. 111-120
10 p.
|
artikel
|
| 13 |
Oral absorption of β-lactams by intestinal peptide transport proteins
|
Dantzig, Anne H.
|
|
1997
|
23 |
1-3 |
p. 63-76
14 p.
|
artikel
|
| 14 |
Preface
|
Smith, Philip
|
|
1997
|
23 |
1-3 |
p. 1-
1 p.
|
artikel
|
| 15 |
Selection of development candidates based on in vitro permeability measurements
|
Lee, Chao-Pin
|
|
1997
|
23 |
1-3 |
p. 47-62
16 p.
|
artikel
|
| 16 |
Simulation models to predict oral drug absorption from in vitro data
|
Grass, George M.
|
|
1997
|
23 |
1-3 |
p. 199-219
21 p.
|
artikel
|
| 17 |
The effect of chemical modifications on octanol/water partition (log D) and permeabilities across Caco-2 monolayers
|
Rubas, Werner
|
|
1997
|
23 |
1-3 |
p. 157-162
6 p.
|
artikel
|
| 18 |
The use of rabbit intestinal permeability as an in vitro assay in the search for orally active GPIIb/IIIa antagonists
|
Samanen, James M.
|
|
1997
|
23 |
1-3 |
p. 133-142
10 p.
|
artikel
|
Tijdschrift beschrijving